Heiner Dreismann's most recent trade in Myriad Genetics, Inc. was a trade of 49,796 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics, Inc. | Heiner Dreismann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 49,796 | 171,444 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Heiner Dreismann | Director | Sale of securities on an exchange or to another person at price $ 27.05 per share. | 09 Sep 2024 | 10,000 | 121,648 (0%) | 0% | 27.1 | 270,520 | Common Stock |
| Myriad Genetics, Inc. | Heiner Dreismann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 15,695 | 131,648 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Heiner Dreismann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 15,151 | 115,953 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics, Inc. | Heiner Dreismann | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 17,275 | 100,802 (0%) | 0% | 0 | Common Stock |